Pierre Chevalier

523 total citations
41 papers, 349 citations indexed

About

Pierre Chevalier is a scholar working on General Health Professions, Epidemiology and Surgery. According to data from OpenAlex, Pierre Chevalier has authored 41 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in General Health Professions, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Pierre Chevalier's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Healthcare Systems and Practices (4 papers) and Aquatic Ecosystems and Phytoplankton Dynamics (3 papers). Pierre Chevalier is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Healthcare Systems and Practices (4 papers) and Aquatic Ecosystems and Phytoplankton Dynamics (3 papers). Pierre Chevalier collaborates with scholars based in United States, Belgium and Canada. Pierre Chevalier's co-authors include Suzanne Gingras, Geneviève Brisson, Benoît Lévesque, Denis Gauvin, Nathalie Fortin, Charles W. Greer, David F. Bird, Mark Lamotte, Pascal Michel and Mark Sostek and has published in prestigious journals such as The Science of The Total Environment, Annals of the Rheumatic Diseases and BMC Psychiatry.

In The Last Decade

Pierre Chevalier

37 papers receiving 324 citations

Peers

Pierre Chevalier
Biljana Mijović Bosnia and Herzegovina
Anna Krakowiak Poland
Cynthia J. Lin United States
Matthew C. Phillips United States
Dina Dobraca United States
Krunoslav Capak Croatia
James G. Parker United States
Lauren Rodriguez United States
Samuel H. Sandifer United States
Kamani Wanigasuriya Sri Lanka
Biljana Mijović Bosnia and Herzegovina
Pierre Chevalier
Citations per year, relative to Pierre Chevalier Pierre Chevalier (= 1×) peers Biljana Mijović

Countries citing papers authored by Pierre Chevalier

Since Specialization
Citations

This map shows the geographic impact of Pierre Chevalier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Chevalier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Chevalier more than expected).

Fields of papers citing papers by Pierre Chevalier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Chevalier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Chevalier. The network helps show where Pierre Chevalier may publish in the future.

Co-authorship network of co-authors of Pierre Chevalier

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Chevalier. A scholar is included among the top collaborators of Pierre Chevalier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Chevalier. Pierre Chevalier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chevalier, Pierre, et al.. (2022). Hospital-acquired infections after acute ischaemic stroke and its association with healthcare-related costs and functional outcome. Acta Neurologica Belgica. 122(5). 1281–1287. 6 indexed citations
2.
Cai, Rui, Pierre Chevalier, Martin Desseilles, et al.. (2022). Assessment of risk factors of treatment discontinuation among patients on paliperidone palmitate and risperidone microspheres in France, Germany and Belgium. BMC Psychiatry. 22(1). 382–382. 3 indexed citations
3.
Chevalier, Pierre, et al.. (2021). Assessing the use of antibiotics and the burden of varicella in Belgium using a retrospective GP database analysis. BMC Infectious Diseases. 21(1). 1150–1150. 7 indexed citations
4.
Morlock, Robert, Pierre Chevalier, Laura Horne, et al.. (2016). Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis. Rheumatology and Therapy. 3(1). 53–75. 5 indexed citations
5.
Chevalier, Pierre, et al.. (2016). Hospitalization Cost and Length of Stay Associated with HPV-Related Diseases. Value in Health. 19(7). A611–A611. 1 indexed citations
6.
Nyberg, Fredrik, Laura Horne, Robert Morlock, et al.. (2016). Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis. Advances in Therapy. 33(7). 1180–1198. 14 indexed citations
7.
Chevalier, Pierre & Michel Lamotte. (2015). Hospitalization Cost and Length of Stay Associated with Ophthalmological Surgery Depending on the Diabetic Status. Value in Health. 18(7). A604–A604. 1 indexed citations
8.
9.
Lévesque, Benoît, Pierre Chevalier, Denis Gauvin, et al.. (2013). Prospective study of acute health effects in relation to exposure to cyanobacteria. The Science of The Total Environment. 466-467. 397–403. 97 indexed citations
10.
Body, Jean‐Jacques, Pierre Chevalier, Oliver Günther, Guy Hechmati, & Mark Lamotte. (2013). The economic burden associated with skeletal-related events in patients with bone metastases secondary to solid tumors in Belgium. Journal of Medical Economics. 16(4). 539–546. 22 indexed citations
11.
Turgeon, Patricia, Pascal Michel, Patrick Levallois, et al.. (2012). Antimicrobial‐Resistant Escherichia coli in Public Beach Waters in Quebec. Canadian Journal of Infectious Diseases and Medical Microbiology. 23(2). e20–5. 15 indexed citations
12.
Turgeon, Patricia, Pascal Michel, Patrick Levallois, et al.. (2011). Agroenvironmental Determinants Associated with the Presence of Antimicrobial‐resistant Escherichia coli in Beach Waters in Quebec, Canada. Zoonoses and Public Health. 58(6). 432–439. 9 indexed citations
13.
Spinewine, Anne, Veerle Foulon, Jan De Lepeleire, et al.. (2010). Seamless care with regard to medications between hospital and home. 5 indexed citations
14.
Spinewine, Anne, Veerle Foulon, Jan De Lepeleire, et al.. (2010). Continuité du traitement médicamenteux entre lhôpital et le domicile. 1 indexed citations
15.
Foulon, Veerle, Jan De Lepeleire, Pierre Chevalier, et al.. (2010). [How to improve the continuity of pharmacotherapy at hospital admission and discharge].. PubMed. 105–9. 2 indexed citations
16.
Foulon, Veerle, Siska Desplenter, Steven Simoens, et al.. (2010). Comment optimiser la continuité du traitement médicamenteux entre l'hôpital et le domicile. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 65(4). 105–109. 1 indexed citations
17.
Spinewine, Anne, Veerle Foulon, Jan De Lepeleire, et al.. (2010). Continuïteit van de medicamenteuze behandeling tussen ziekenhuis en thuis. 5 indexed citations
18.
Stichele, Robert Vander, Carine Van de Voorde, Marc Bauwens, et al.. (2006). Medication use in rest and nursing homes in Belgium. 7 indexed citations
19.
Stichele, Robert Vander, Carine Van de Voorde, Marc Bauwens, et al.. (2006). Geneesmiddelen gebruik in de Belgische rusthuizen en rust- en verzorgingstehuizen. 25 indexed citations
20.
Cornu, A., et al.. (1980). [Some biochemical results obtained from the Touboro (Cameroun) onchocerciasis focus].. PubMed. 72(1). 40–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Biljana Mijović Breakdown of academic impact, for papers by Anna Krakowiak Breakdown of academic impact, for papers by Cynthia J. Lin Breakdown of academic impact, for papers by Matthew C. Phillips Breakdown of academic impact, for papers by Dina Dobraca Breakdown of academic impact, for papers by Krunoslav Capak Breakdown of academic impact, for papers by James G. Parker Breakdown of academic impact, for papers by Lauren Rodriguez Breakdown of academic impact, for papers by Samuel H. Sandifer Breakdown of academic impact, for papers by Kamani Wanigasuriya
Rankless by CCL
2026